-+ 0.00%
-+ 0.00%
-+ 0.00%

Hemab Therapeutics Appoints Keli Walbert to Board of Directors

PUBT·11/10/2026 12:12:18
Hemab Therapeutics Appoints Keli Walbert to Board of Directors
  • Hemab Therapeutics appointed Keli Walbert to its board in September 2026; she serves on the audit committee.
  • Walbert brings more than 20 years of biopharmaceutical commercial leadership experience, including as executive vice president, U.S. Commercial at Horizon Therapeutics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hemab Therapeutics Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611100700PRIMZONEFULLFEED9874261) on November 10, 2026, and is solely responsible for the information contained therein.